Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Kern

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Journal of Managed Care & Specialty Pharmacy|March 23, 2016
Health Care Utilization and Costs After Initiating Budesonide/Formoterol Combination or Fluticasone/Salmeterol Combination Among COPD Patients New to ICS/LABA TreatmentJill R Davis, David M Kern, Setareh A Williams, et al.
Nature Structural & Molecular Biology|March 17, 2023
Structural basis for assembly and lipid-mediated gating of LRRC8A:C volume-regulated anion channelsDavid M Kern, Julia Bleier, Somnath Mukherjee, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 10, 2015
Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatmentsFrank Trudo, David M Kern, Jill R Davis, et al.
American Health & Drug Benefits|June 20, 2017
Impact of Nonadherence to Inhaled Corticosteroid/LABA Therapy on COPD Exacerbation Rates and Healthcare Costs in a Commercially Insured US PopulationJill R Davis, Bingcao Wu, David M Kern, et al.
Schizophrenia Research|May 22, 2012
Low maternal hemoglobin during pregnancy and diminished neuromotor and neurocognitive performance in offspring with schizophreniaLauren M Ellman, Sophia Vinogradov, William S Kremen, et al.
Postgraduate Medicine|November 14, 2019
Postmarketing studies program to assess the risks and benefits of long-term use of extended-release/long-acting opioids among chronic pain patientsPaul M Coplan, M Soledad Cepeda, Kenneth R Petronis, et al.
Vaccine|September 18, 2020
Rate of preventative vaccine use and vaccine beliefs among a commercially insured populationKarri A Bauer, Kelly Johnson, Judith J Stephenson, et al.
Clinicoeconomics and Outcomes Research : CEOR|August 28, 2020
Healthcare Costs of Diabetes and Microvascular and Macrovascular Disease in Individuals with Incident Type 2 Diabetes Mellitus: A Ten-Year Longitudinal StudyJay Visaria, Neeraj N Iyer, Amit D Raval, et al.
BMC Research Notes|January 10, 2022
Update on prevalence of diagnosed systemic lupus erythematosus (SLE) by major health insurance types in the US in 2016Yiting Wang, Laura L Hester, Jennifer Lofland, et al.
Pharmacoeconomics - Open|August 28, 2024
Clinicians' Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice ExperimentAlexander Keenan, Chiara Whichello, Hoa H Le, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Journal of Managed Care & Specialty Pharmacy|March 23, 2016
Health Care Utilization and Costs After Initiating Budesonide/Formoterol Combination or Fluticasone/Salmeterol Combination Among COPD Patients New to ICS/LABA TreatmentJill R Davis, David M Kern, Setareh A Williams, et al.
Nature Structural & Molecular Biology|March 17, 2023
Structural basis for assembly and lipid-mediated gating of LRRC8A:C volume-regulated anion channelsDavid M Kern, Julia Bleier, Somnath Mukherjee, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 10, 2015
Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatmentsFrank Trudo, David M Kern, Jill R Davis, et al.
American Health & Drug Benefits|June 20, 2017
Impact of Nonadherence to Inhaled Corticosteroid/LABA Therapy on COPD Exacerbation Rates and Healthcare Costs in a Commercially Insured US PopulationJill R Davis, Bingcao Wu, David M Kern, et al.
Schizophrenia Research|May 22, 2012
Low maternal hemoglobin during pregnancy and diminished neuromotor and neurocognitive performance in offspring with schizophreniaLauren M Ellman, Sophia Vinogradov, William S Kremen, et al.
Postgraduate Medicine|November 14, 2019
Postmarketing studies program to assess the risks and benefits of long-term use of extended-release/long-acting opioids among chronic pain patientsPaul M Coplan, M Soledad Cepeda, Kenneth R Petronis, et al.
Vaccine|September 18, 2020
Rate of preventative vaccine use and vaccine beliefs among a commercially insured populationKarri A Bauer, Kelly Johnson, Judith J Stephenson, et al.
Clinicoeconomics and Outcomes Research : CEOR|August 28, 2020
Healthcare Costs of Diabetes and Microvascular and Macrovascular Disease in Individuals with Incident Type 2 Diabetes Mellitus: A Ten-Year Longitudinal StudyJay Visaria, Neeraj N Iyer, Amit D Raval, et al.
BMC Research Notes|January 10, 2022
Update on prevalence of diagnosed systemic lupus erythematosus (SLE) by major health insurance types in the US in 2016Yiting Wang, Laura L Hester, Jennifer Lofland, et al.
Pharmacoeconomics - Open|August 28, 2024
Clinicians' Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice ExperimentAlexander Keenan, Chiara Whichello, Hoa H Le, et al.
Pageof 10